Pfizer reported Tuesday a loss following a sharp fall in the sales of its Covid-19 vaccine and therapeutic from pandemic peaks.
GlaxoSmithKline sued Pfizer on Wednesday over patent infringement, alleging the US drugmaker's RSV vaccine steals key elements of the British company's version.
Pfizer reported a steep drop in profits Tuesday on much lower Covid-related revenues as it curtailed its full-year sales outlook, in part due to tornado damage to a key manufacturing facility.
Pfizer's profits in the first quarter were $5.5 billion, down 30 percent from the year-ago period.
They were sold at pharmacies nationwide.
The cases were not related to Pfizer's new vaccine, the pharmaceutical giant claimed, in contrast to the investigator's assessments.
Britain's health regulatory agency approved its first COVID-19 booster targeting Omicron BA.4 and BA.5 variants.
For now, the new booster shots are free of charge for everyone.
Those who use the drug should immediately consult their health care provider.
When will Pfizer's COVID-19 pill become widely available?
Novavax has conducted early data on its vaccine that targets COVID-19 and the flu
Regulators in this country have authorized the use of Moderna’s vaccine for kids
Pfizer shared promising results Thursday regarding its COVID-19 booster dose for children aged 5 to 11.
Two studies published Monday concluded the risks of heart inflammation following COVID-19 vaccination
Moderna confirmed Friday that 764,000 doses of its notable COVID-19 vaccine will be revoked
In a meeting Wednesday, the FDA said that regulators need to determine if additional COVID doses are needed by this time
Regulators discuss the need for additional COVID-19 booster doses
The CDC compared the risks of cardiovascular complications from COVID-19 infection and vaccination.
A study found that pregnancy, along with other comorbidities, can increase the chance of getting a breakthrough COVID-19 infection.
The CDC advised recipients of Johnson & Johnson’s single-dose vaccine to get a booster with one of the mRNA vaccines.
A fourth COVID-19 vaccine dose has been approved by the Food and Drug Administration for those 50 or older.
The FDA will likely approve a second COVID-19 booster shot for adults next week
